In acquired EGFR-TKI-resistant NSCLC cells with MET amplification, EGFR lost its regulation on MET, and whether the HIF-1 pathway remained the regulation on MET kept unclear [7]. Here, HIF1A is linked to non-small cell lung carcinoma.